IEQ Capital’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-384
| Closed | -$8.06K | – | 1893 |
|
2025
Q1 | $8.06K | Hold |
384
| – | – | ﹤0.01% | 1603 |
|
2024
Q4 | $9.55K | Hold |
384
| – | – | ﹤0.01% | 1324 |
|
2024
Q3 | $6.48K | Hold |
384
| – | – | ﹤0.01% | 1155 |
|
2024
Q2 | $10.8K | Hold |
384
| – | – | ﹤0.01% | 1000 |
|
2024
Q1 | $115K | Hold |
384
| – | – | ﹤0.01% | 921 |
|
2023
Q4 | $90.5K | Hold |
384
| – | – | ﹤0.01% | 885 |
|
2023
Q3 | $57.5K | Hold |
384
| – | – | ﹤0.01% | 909 |
|
2023
Q2 | $66.8K | Hold |
384
| – | – | ﹤0.01% | 873 |
|
2023
Q1 | $48.3K | Hold |
384
| – | – | ﹤0.01% | 877 |
|
2022
Q4 | $116K | Hold |
384
| – | – | ﹤0.01% | 764 |
|
2022
Q3 | $21K | Hold |
384
| – | – | ﹤0.01% | 835 |
|
2022
Q2 | $23K | Hold |
384
| – | – | ﹤0.01% | 792 |
|
2022
Q1 | $44K | Hold |
384
| – | – | ﹤0.01% | 803 |
|
2021
Q4 | $55K | Hold |
384
| – | – | ﹤0.01% | 716 |
|
2021
Q3 | $84K | Hold |
384
| – | – | ﹤0.01% | 682 |
|
2021
Q2 | $89K | Hold |
384
| – | – | ﹤0.01% | 602 |
|
2021
Q1 | $115K | Buy |
+384
| New | +$115K | ﹤0.01% | 472 |
|